All roads lead to disconnection?: Traumatic axonal injury revisited

被引:364
作者
Büki, A [1 ]
Povlishock, JT
机构
[1] Univ Pecs, Fac Med, Dept Neurosurg, Pecs, Hungary
[2] Univ Pecs, Ctr Med & Hlth Sci, Pecs, Hungary
[3] Virginia Commonwealth Univ, Coll Med, Dept Anat & Neurobiol, Richmond, VA USA
关键词
caspase; calpain; spectrin; traumatic axonal injury;
D O I
10.1007/s00701-005-0674-4
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Traumatic brain injury (TBI) evokes widespread/diffuse axonal injury (TAI) significantly contributing to its morbidity and mortality. While classic theories suggest that traumatically injured axons are mechanically torn at the moment of injury, studies in the last two decades have not supported this premise in the majority of injured axons. Rather, current thought considers TAI a progressive process evoked by the tensile forces of injury, gradually evolving from focal axonal alteration to ultimate disconnection. Recent observations have demonstrated that traumatically induced focal axolemmal permeability leads to local influx of Ca2+ stop with the subsequent activation of the cysteine proteases, calpain and caspase, that then play a pivotal role in the ensuing pathogenesis of TAI via proteolytic digestion of brain spectrin, a major constituent of the subaxolemmal cytoskeletal network, the "membrane skeleton". In this pathological progression this local Ca2+ stop overloading with the activation of calpains also initiates mitochondrial injury that results in the release of cytochrome-c, with the activation of caspase. Both the activated calpain and caspases then participate in the degradation of the local axonal cytoskeleton causing local axonal failure and disconnection. In this review, we summarize contemporary thought on the pathogenesis of TAI, while discussing the potential diversity of pathological processes observed within various injured fiber types. The anterograde and retrograde consequences of TAI are also considered together with a discussion of various experimental therapeutic approaches capable of attenuating TAI.
引用
收藏
页码:181 / +
页数:14
相关论文
共 110 条
  • [91] The immunophilin ligand FK506 attenuates axonal injury in an impact-acceleration model of traumatic brain injury
    Singleton, RH
    Stone, JR
    Okonkwo, DO
    Pellicane, AJ
    Povlishock, JT
    [J]. JOURNAL OF NEUROTRAUMA, 2001, 18 (06) : 607 - 614
  • [92] Factors directly affecting impulse transmission in inflammatory demyelinating disease: recent advances in our understanding
    Smith, KJ
    Hall, SM
    [J]. CURRENT OPINION IN NEUROLOGY, 2001, 14 (03) : 289 - 298
  • [93] Intra-axonal neurofilament compaction does not evoke local axonal swelling in all traumatically injured axons
    Stone, JR
    Singleton, RH
    Povlishock, JT
    [J]. EXPERIMENTAL NEUROLOGY, 2001, 172 (02) : 320 - 331
  • [94] STRICH SJ, 1961, LANCET, V2, P443
  • [95] The immunophilin ligand FK506 attenuates the axonal damage associated with rapid rewarming following posttraumatic hypothermia
    Suehiro, E
    Singleton, RH
    Stone, JR
    Povlishock, JT
    [J]. EXPERIMENTAL NEUROLOGY, 2001, 172 (01) : 199 - 210
  • [96] Distinct caspase cascades are initiated in receptor-mediated and chemical-induced apoptosis
    Sun, XM
    MacFarlane, M
    Zhuang, JG
    Wolf, BB
    Green, DR
    Cohen, GM
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (08) : 5053 - 5060
  • [97] Molecular characterization of mitochondrial apoptosis-inducing factor
    Susin, SA
    Lorenzo, HK
    Zamzami, N
    Marzo, I
    Snow, BE
    Brothers, GM
    Mangion, J
    Jacotot, E
    Costantini, P
    Loeffler, M
    Larochette, N
    Goodlett, DR
    Aebersold, R
    Siderovski, DP
    Penninger, JM
    Kroemer, G
    [J]. NATURE, 1999, 397 (6718) : 441 - 446
  • [98] Mitochondria as regulators of apoptosis: doubt no more
    Susin, SA
    Zamzami, N
    Kroemer, G
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS, 1998, 1366 (1-2): : 151 - 165
  • [99] Mitochondrial release of caspase-2 and -9 during the apoptotic process
    Susin, SA
    Lorenzo, HK
    Zamzami, N
    Marzo, I
    Brenner, C
    Larochette, N
    Prévost, MC
    Alzari, PM
    Kroemer, G
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1999, 189 (02) : 381 - 393
  • [100] Trost LC, 1996, J PHARMACOL EXP THER, V278, P1000